DeepMed Research

Charité - Universitätsmedizin Berlin

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Private

Established: 1710-01-01

Employees: 10K

Market Cap: -

Website: http://www.charite.de

Clinical Trials

Coronary CT Angiography Using 320-Row Volume CT in Patients With Atrial Fibrillation

Completed

Conditions: Atrial Fibrillation

First Posted Date: 2009-08-28

Last Posted Date: 2013-05-03

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 54

Registration Number: NCT00968279

Locations: 🇩🇪
Charité, Berlin, Germany

Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia

Phase 3

Completed

Conditions: Androgenetic Alopecia
Female Pattern Hair Loss

Interventions: Drug: minoxidil

First Posted Date: 2009-08-13

Last Posted Date: 2011-11-18

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 113

Registration Number: NCT00958750

Locations: 🇩🇪
Charité-Universitaetsmedizin; Clinical Research Center for Hair and Skin Science, Berlin, Germany

Long Time Metabolic Changes Induced by Genetically Modified Potatoes

Not Applicable

Conditions: Glucose Metabolism
Hormonal Changes
Satiety

First Posted Date: 2009-08-06

Last Posted Date: 2009-08-25

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 20

Registration Number: NCT00953602

Locations: 🇩🇪
Charité, Dpt. of Endocrinology, Diabetes and Nutrition, Berlin, Germany

Hormonal and Metabolic Effects of Weight Loss

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: lifestyle

First Posted Date: 2009-08-06

Last Posted Date: 2017-12-15

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 290

Registration Number: NCT00953264

Locations: 🇩🇪
Charite, Berlin, Germany

Metabolic Changes Induced by Genetically Modified Potatoes

Not Applicable

Conditions: Endocrine Metabolism
Glucose Metabolism
Satiety

Interventions: Other: Genetically modified potatoes

First Posted Date: 2009-08-06

Last Posted Date: 2009-08-25

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 50

Registration Number: NCT00953966

Locations: 🇩🇪
Charité, Dept. of Endocrinology, Diabetes and Nutrition, Berlin, Germany

Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease

Phase 2

Completed

Conditions: Alzheimer's Disease

Interventions: Drug: Epigallocatechin-Gallate
Drug: Placebo

First Posted Date: 2009-08-04

Last Posted Date: 2021-07-29

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 21

Registration Number: NCT00951834

Locations: 🇩🇪
Charité Universitätsmedizin Berlin Klinik für Psychiatrie und Psychotherapie, Berlin, Germany
🇩🇪
Klinik für Neurologie, Ulm, Germany
🇩🇪
Charite University Medicine Berlin, Berlin, Germany

The Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic Sclerosis

Not Applicable

Completed

Conditions: Raynaud's Phenomenon
Systemic Sclerosis

Interventions: Other: Biofeedback
Other: Deep oscillation

First Posted Date: 2009-07-27

Last Posted Date: 2009-07-27

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 28

Registration Number: NCT00946738

Locations: 🇩🇪
Department of Physical Medicine and Rehabilitation , Charité University Hospital Berlin, Berlin, 10117, Germany

Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma

Phase 2

Conditions: Recurrent or Refractory Primary CNS Lymphoma

Interventions: Drug: temsirolimus

First Posted Date: 2009-07-21

Last Posted Date: 2013-04-17

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 37

Registration Number: NCT00942747

Locations: 🇩🇪
Neurology, Knappschaftskrankenhaus Bochum, Bochum University, Bochum, Germany
🇩🇪
Hematology, Klinikum Frankfurt/Oder, Frankfurt an der Oder, Germany
🇩🇪
Klinikum Grosshadern, University Hospital Munich, Munich, Germany

and more 3 locations

Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer

Phase 1

Conditions: Breast Cancer

First Posted Date: 2009-06-30

Last Posted Date: 2011-01-26

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 54

Registration Number: NCT00930475

Locations: 🇩🇪
Charité, university medicine, Berlin, CCM, Berlin, Germany

Growth Hormone and Glucose Metabolism

Phase 4

Completed

Conditions: Growth Hormone Deficiency

Interventions: Drug: recombinant human Growth Hormone (Genotropin® )

First Posted Date: 2009-06-30

Last Posted Date: 2009-06-30

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 6

Registration Number: NCT00929799

Locations: 🇩🇪
Charite Campus Benjamin Franklin, Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy